Following a limited submission
AWMSG advice |
|
| Status: Recommended | |
Progesterone (Prometrium®) is recommended for use in NHS Wales for the prevention of miscarriage in women presenting with bleeding in the first trimester of pregnancy and have a history of recurrent miscarriages. This recommendation applies only in circumstances where the approved Welsh Patient Access Scheme (WPAS) is utilised or where the list / contract price is equivalent to or lower than the WPAS price. |
|
Medicine details |
|
| Medicine name | progesterone (Prometrium®) |
| Formulation | 400 mg vaginal capsules |
| Reference number | 6820 |
| Indication | For the prevention of miscarriage in women presenting with bleeding in the first trimester of pregnancy and have a history of recurrent miscarriages |
| Company | Besins Healthcare UK Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Assessment type | Limited |
| Status | Recommended |
| Scrutiny Panel meeting date | 07/08/2025 |
| LOWMAG meeting date | 15/04/2026 |
| AWMSG meeting date | 20/05/2026 |
| Date of issue | 26/05/2026 |
| Commercial arrangement | WPAS |